These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1089 related articles for article (PubMed ID: 32152499)

  • 1. The tubular hypothesis of nephron filtration and diabetic kidney disease.
    Vallon V; Thomson SC
    Nat Rev Nephrol; 2020 Jun; 16(6):317-336. PubMed ID: 32152499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Effects of Sodium-Glucose Co-Transporter Inhibitors.
    Thomson SC; Vallon V
    Am J Cardiol; 2019 Dec; 124 Suppl 1(Suppl 1):S28-S35. PubMed ID: 31741437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice.
    Vallon V; Gerasimova M; Rose MA; Masuda T; Satriano J; Mayoux E; Koepsell H; Thomson SC; Rieg T
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F194-204. PubMed ID: 24226524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration.
    Zhang J; Cai J; Cui Y; Jiang S; Wei J; Kim YC; Chan J; Thalakola A; Le T; Xu L; Wang L; Jiang K; Wang X; Wang H; Cheng F; Buggs J; Koepsell H; Vallon V; Liu R
    Kidney Int; 2022 Mar; 101(3):541-550. PubMed ID: 34843754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renal tubule-specific knockdown of the Na
    Onishi A; Fu Y; Darshi M; Crespo-Masip M; Huang W; Song P; Patel R; Kim YC; Nespoux J; Freeman B; Soleimani M; Thomson S; Sharma K; Vallon V
    Am J Physiol Renal Physiol; 2019 Aug; 317(2):F419-F434. PubMed ID: 31166707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia.
    Zhang J; Wei J; Jiang S; Xu L; Wang L; Cheng F; Buggs J; Koepsell H; Vallon V; Liu R
    J Am Soc Nephrol; 2019 Apr; 30(4):578-593. PubMed ID: 30867247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.
    Vallon V; Richter K; Blantz RC; Thomson S; Osswald H
    J Am Soc Nephrol; 1999 Dec; 10(12):2569-76. PubMed ID: 10589696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis.
    Hallow KM; Gebremichael Y; Helmlinger G; Vallon V
    Am J Physiol Renal Physiol; 2017 May; 312(5):F819-F835. PubMed ID: 28148531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney.
    Vallon V; Thomson SC
    Annu Rev Physiol; 2012; 74():351-75. PubMed ID: 22335797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Computational Model of Kidney Function in a Patient with Diabetes.
    Hu R; Layton A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.
    Vallon V; Thomson SC
    Diabetologia; 2017 Feb; 60(2):215-225. PubMed ID: 27878313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubular reabsorption and diabetes-induced glomerular hyperfiltration.
    Persson P; Hansell P; Palm F
    Acta Physiol (Oxf); 2010 Sep; 200(1):3-10. PubMed ID: 20518753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System.
    Poursharif S; Hamza S; Braam B
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?
    Mazzucato M; Fioretto P; Avogaro A
    Diabetes Obes Metab; 2020 Sep; 22(9):1511-1515. PubMed ID: 32350981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Pathogenesis of Glomerular Hyperfiltration in Early Diabetic Kidney Disease.
    Yang Y; Xu G
    Front Endocrinol (Lausanne); 2022; 13():872918. PubMed ID: 35663316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats.
    Thomson SC; Vallon V
    Am J Physiol Renal Physiol; 2021 May; 320(5):F761-F771. PubMed ID: 33645318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotective Effects of SGLT2 Inhibitors.
    Vallon V
    Heart Fail Clin; 2022 Oct; 18(4):539-549. PubMed ID: 36216484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.